Product Information
DOXEPIN 150 MG CAPSULE is a generic product labeled by Endo USA Inc., priced at $0.5364 per EA under NDC 49884022205. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Nov 9, 1987.
Strength
150 mg/1
Manufacturer
Endo USA Inc.NDC
49884022205
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DOXEPIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA071422FDA Approved
11/9/1987
On Market Since
11/9/1987
Pharmacological Classes
Price Statistics
The NADAC for DOXEPIN 150 MG CAPSULE has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 28.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5364 per EA |
|---|---|
| All-time high | $0.8872 (Sep 14, 2016) |
| All-time low | $0.3152 (Jul 17, 2024) |
| 52-week high | $0.5631 |
| 52-week low | $0.4907 |
| Median price | $0.6815 |
| Average price | $0.6640 |
| Largest weekly change | +48.3% (Aug 21, 2024) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Endo USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Doxepin Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Tricyclic Antidepressant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DOXEPIN 150 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for DOXEPIN 150 MG CAPSULE, manufactured by Endo USA Inc., is $0.5364 per EA (NDC 49884022205), effective Sep 30, 2026.
How has the price of DOXEPIN 150 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for DOXEPIN 150 MG CAPSULE has risen 28.4%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for DOXEPIN 150 MG CAPSULE?
Since Nov 28, 2013, the NADAC for DOXEPIN 150 MG CAPSULE has ranged from a low of $0.3152 (Jul 17, 2024) to a high of $0.8872 (Sep 14, 2016), with a median of $0.6815 per EA.
Are there cheaper alternatives to DOXEPIN 150 MG CAPSULE?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as DOXEPIN 150 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures DOXEPIN 150 MG CAPSULE?
DOXEPIN 150 MG CAPSULE (NDC 49884022205) is labeled by Endo USA Inc., and CMS classifies it as a generic product.